Court restricts abortion access across the US by blocking the mailing of mifepristone

A federal appeals court has temporarily blocked mifepristone from being dispensed by mail, effectively reinstating a requirement that the abortion drug be obtained in person. This ruling significantly restricts access to medication abortion, which has become the most common method of abortion in the U.S. since the Supreme Court overturned Roe v. Wade in 2022. The NPR/AP reporting is sourced through a major wire service and corroborated across Reuters, CNN, NBC, and the LA Times—all reporting the same core facts: the court granted Louisiana's request, the block is temporary, and the impact is nationwide. The article description provides the essential facts but lacks specificity on key details visible in competing coverage (the role of Louisiana as petitioner, the telehealth component of the restriction, or the timeline of the temporary order), suggesting the headline and description are accurate but somewhat surface-level compared to fuller reporting elsewhere.